BA
47
4
D
41
-4
CCL
81
16
ALL
56
2
CAT
58
-8
APA
53
5
BRK.B
33
-14
C
82
3
CNP
49
-6
BAC
77
5
AME
72
6
AEP
61
-3
EMC
47
11
CHRW
82
3
AIZ
78
2
BWA
53
-7
BAX
38
-12
ACN
56
2
CMA
70
5
VIX
22
-14
BA
47
4
D
41
-4
CCL
81
16
ALL
56
2
CAT
58
-8
APA
53
5
BRK.B
33
-14
C
82
3
CNP
49
-6
BAC
77
5
AME
72
6
AEP
61
-3
EMC
47
11
CHRW
82
3
AIZ
78
2
BWA
53
-7
BAX
38
-12
ACN
56
2
CMA
70
5
VIX
22
-14
Financhill
Back

Impala Platinum Holdings Ltd. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
73

IMPUY
Impala Platinum Holdings Ltd.

Last Price:
$14.66
Seasonality Move:
9.95%
Sell
31

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Buy
73
Impala Platinum Holdings Ltd. (IMPUY) is a Buy

Is Impala Platinum Holdings Ltd. a Buy, Sell or Hold?

  • The current Impala Platinum Holdings Ltd. [IMPUY] share price is $14.66. The Score for IMPUY is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • IMPUY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IMPUY Stock Price Chart

What is Impala Platinum Holdings Ltd.'s stock price today?

  • The Impala Platinum Holdings Ltd. share price today is $14.66
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMPUY is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

IMPUY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.73 Buy
Relative Strength Index (14 RSI): 74.6 Buy
Chaikin Money Flow: 41071 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

IMPUY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.78 Buy
20-day SMA: 12.87 Buy
50-day SMA: 11.99 Buy
200-day SMA: 9.41 Buy
8-day EMA: 13.88 Buy
20-day EMA: 13.07 Buy
50-day EMA: 12.23 Buy
200-day EMA: 9.91 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

Impala Platinum Holdings Ltd. Earnings Growth & IMPUY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Impala Platinum Holdings Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):